Domesco Medical Import-Export JSC

As of June 30, 2026, Domesco Medical Import-Export JSC carries a market capitalization of 2.05T, placing it among publicly traded companies globally. Its enterprise value stands at 1.46T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Domesco Medical Import-Export JSC has 34.73M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Domesco Medical Import-Export JSC maintains a current ratio of 5.95, meaning it holds 6.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Domesco Medical Import-Export JSC recorded 50.33B in income tax expense.

As of the close on October 22, 2026, Domesco Medical Import-Export JSC's stock has declined approximately 7.33% over the past 52 weeks. The 50-day moving average sits at 56,830.00, while the 200-day moving average is 58,851.00.

These figures are as of June 30, 2026. Total book value stands at 1.68T, with working capital of 1.46T providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield reaches 4.24, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Domesco Medical Import-Export JSC shareholders.

Domesco Medical Import-Export JSC's most recent stock split took place on June 16, 2016 with a 10:13 split ratio.